¿ÞÂÊ ¸Þ´º ŸÀÌƲ À̹ÌÁö
¿¬±¸µ¿Çâ

Home < ¿­¸°¸¶´ç < ¿¬±¸µ¿Çâ

       ½Ã½ºÅÛ»ý¹°ÇÐÀÇ ÇÕ¼º»ý¹°ÇÐ Àû¿ëÀ» À§ÇÑ Ç¥ÁØÈ­(¿¬¼¼´ë ±èÁöÇö ±³¼ö, ÀÌÃæÈÆ ¹Ú»ç)
       jfk1@yonsei.ac.kr        
       ±èÁöÇö        2013.07.01 10:47        14296
´Ù¿î·Îµå : ½Ã½ºÅÛ»ý¹°ÇÐÀÇ ÇÕ¼º»ý¹°ÇÐ Àû¿ëÀ» À§ÇÑ Ç¥ÁØÈ­(¿¬¼¼´ë ÀÌÃæÈÆ, ±èÁöÇö).pdf(417 Kb)
 

½Ã½ºÅÛ»ý¹°ÇÐÀÇ ÇÕ¼º»ý¹°ÇÐ Àû¿ëÀ» À§ÇÑ Ç¥ÁØÈ­

 

 

 

ÀÌÃæÈÆ ¹Ú»ç, ±èÁöÇö ±³¼ö

¿¬¼¼´ëÇб³ ½Ã½ºÅÛ»ý¹°Çаú

 

 

 

1. ½Ã½ºÅÛ»ý¹°Çаú ÇÕ¼º»ý¹°ÇÐ


1990³â´ë Á߹ݺÎÅÍ »ý¹°Çа迡¼­´Â »ý¸í Çö»óÀ» ´ÜÆíÀûÀÎ Çö»óÀÌ ¾Æ´Ñ ÇϳªÀÇ ½Ã½ºÅÛ ¼öÁØ¿¡¼­ ºÐ¼®ÇÏ°í ÀÌÇØÇÏ·Á´Â ½Ãµµ°¡ ½ÃÀ۵Ǿú°í, ÀÌ·¯ÇÑ ¿òÁ÷ÀÓÀº ½Ã½ºÅÛ»ý¹°ÇÐÀ̶ó´Â À̸§À¸·Î ³Î¸® ¾Ë·ÁÁö°Ô µÇ¾ú´Ù. ¼¼Æ÷ Áֱ⿡ ´ëÇÑ ¼öÇÐÀû ¸ðµ¨ ¼ö¸³¿¡¼­ ÃË¹ßµÈ ½Ã½ºÅÛ»ý¹°ÇÐÀº (Tyson, 2001, Novak, 1993, Chen, 2004), À̳» ±× È°¿ëµµ¸¦ Å©°Ô ÀÎÁ¤¹Þ¾Æ ÀÇ¾à ¹× ´Ù¾çÇÑ »ý¸í°øÇÐ ºÐ¾ß¿¡ Àû¿ëµÇ±â ½ÃÀÛÇÏ¿´°í (Kitano 2002a, Kitano 2002b, Kitano 2000, Ideker 2001), ÃÖ±Ù¿¡´Â Ç×¾Ï Ä¡·áÁ¦ÀÇ ÀÓ»ó ½ÇÇè¿¡µµ ¼öÇÐÀû ¸ðµ¨À» ÀÌ¿ëÇÑ ½Ã½ºÅÛ»ý¹°ÇÐÀû Á¢±Ù¹æ¹ýÀÌ »ç¿ëµÇ°í ÀÖ´Ù (Schoeberl, 2010).
»ý¸íü¸¦ ½Ã½ºÅÛ ¼öÁØ¿¡¼­ ºÐ¼®ÇÏ°í ÀÌÇØÇÒ ¼ö ÀÖ°Ô ÇØ ÁØ ½Ã½ºÅÛ»ý¹°ÇÐÀÇ ¹ßÀüÀº, ´Ù¾çÇÑ »ý¸íü ³»ÀÇ ±â´É ¸ðµâµéÀ» È­ÇÐÀûÀ¸·Î ÇÕ¼ºÇÒ ¼ö ÀÖ°Ô ÇØÁØ ±â¼úÀÇ ¹ß´ÞÀ» ÅëÇØ, ½Ã½ºÅÛ ·¹º§¿¡¼­ÀÇ ÀÌÇظ¦ ½Ã½ºÅÛ ·¹º§¿¡¼­ÀÇ ¼³°è ¹× Á¶ÀÛÀ¸·Î ÀÀ¿ëÇÏ°íÀÚ ÇÏ´Â ÇÕ¼º»ý¹°ÇÐÀÇ ¹ßÀüÀ¸·Î ÀÚ¿¬½º·´°Ô À̾îÁ³´Ù.
´ë¿ë·®À¸·Î ¾ò¾îÁö´Â À¯Àüü ¹× °¢Á¾ ¿À¹Í½º µ¥ÀÌÅ͵éÀ» ½Ã½ºÅÛ ·¹º§¿¡¼­ ºÐ¼®ÇÔÀ¸·Î½á, »ý¸íü ¾ÈÀÇ ¿©·¯ ÀÎÀÚµéÀÌ ¼­·Î ¾î¶»°Ô ¹ÝÀÀÇϸ鼭 ³×Æ®¿öÅ©¸¦ Çü¼ºÇÏ°í ÀÖ´ÂÁö¸¦ À¯Àüü, Àü»çü, ´Ü¹éÁúü, ´ë»çü µî ´Ù¾çÇÑ ·¹º§¿¡¼­ È®ÀÎÇÒ ¼ö ÀÖ°Ô µÇ¾ú°í, À̵éÀ» ÅëÇØ ³×Æ®¿öÅ© ³»ÀÇ ¾î¶°ÇÑ ºÎºÐÀ» °Çµå·Á¾ß ¿øÇÏ´Â È¿°ú¸¦ ¾òÀ» ¼ö ÀÖ´ÂÁö, ³×Æ®¿öÅ© ³»ºÎÀÇ ¾î¶°ÇÑ ¸ðµâÀÌ ³×Æ®¿öÅ© ¾È¿¡¼­ ¾î¶°ÇÑ ±â´ÉÀ» ÇÏ´ÂÁö¿¡ ´ëÇÑ º¸´Ù Á¤È®ÇÑ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ°Ô µÇ¾úÀ» »Ó¸¸ ¾Æ´Ï¶ó, »õ·Î¿î À¯¿ëÇÑ ±â´ÉÀÇ ¸ðµâ¿¡ ´ëÇÑ Á¤º¸¸¦ È®º¸ÇÒ ¼ö ÀÖ°Ô µÇ¾ú´Ù.
¶ÇÇÑ À籸¼ºµÈ ³×Æ®¿öÅ©¸¦ ¹ÙÅÁÀ¸·Î ½Ã¹Ä·¹À̼ÇÀ» ¼öÇàÇÔÀ¸·Î½á, »õ·Î¿î ¸ðµâÀ» ¿ÜºÎ¿¡¼­ ³Ö¾îÁÖ¾úÀ» ¶§ Àüü ³×Æ®¿öÅ©°¡ ÀÌ¿¡ ´ëÇØ ¾î¶»°Ô ¹ÝÀÀÇÏ´ÂÁö, ¿¹»óÄ¡ ¸øÇÑ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇÑ ºÎÀÛ¿ëÀº ¾ø´ÂÁö, ´Ù¾çÇÑ È¯°æ º¯È­¿¡ ´ëÇؼ­µµ »õ·Ó°Ô ±¸¼ºµÈ ½Ã½ºÅÛÀÌ ¾ÈÁ¤ÀûÀ¸·Î ÀÛµ¿ÇÒ ¼ö ÀÖ´ÂÁö µîÀ» ÀνǸ®ÄÚ·Î ¹Ì¸® Å×½ºÆ®Çغ¼ ¼ö ÀÖ°Ô µÇ¾ú´Ù. ´Ù½Ã ¸»Çؼ­, ½Ã½ºÅÛ»ý¹°ÇÐÀÇ ¹ßÀüÀ» ÅëÇØ ÇÕ¼º»ý¹°ÇÐÀº »ý¹°ÇÐÀû ½Ã½ºÅÛÀÇ ¼³°è¸¦ À§ÇÑ °­·ÂÇÑ µµ±¸¸¦ È®º¸ÇÒ ¼ö ÀÖ°Ô µÇ¾ú´Ù (±×¸² 1).

 

±×¸² 1. ½Ã½ºÅÛ»ý¹°Çаú ÇÕ¼º»ý¹°ÇÐ »çÀÌÀÇ ½Ã³ÊÁö È¿°ú (Lanza, 2012)

 

2. ¿À¹Í½º Á¤º¸ ¸ÞŸµ¥ÀÌÅÍ ¹× µ¥ÀÌÅÍ ÀúÀå ¹æ½Ä Ç¥ÁØÈ­


»ý¸íü ³»ºÎÀÇ º¯È­¸¦ ÃøÁ¤Çϱâ À§ÇÑ ´Ù¾çÇÑ ±â¼úÀû ¹ßÀüµéÀº ÀÌÁ¦ »ý¸íü ³»ºÎÀÇ ÀÛÀº ¸ðµâµéÀÇ º¯È­¸¦ ½Ã½ºÅÛ ÀüüÀûÀ¸·Î °üÂûÇÏ°í ±â·ÏÇÒ ¼ö ÀÖ°Ô²û ÇØÁÖ°í ÀÖ´Ù. ƯÈ÷ Next Generation Sequencing (NGS) ±â¼úÀÇ ¹ßÀüÀº À¯ÀüüÀÇ ¿°±â¼­¿­ »Ó¸¸ ¾Æ´Ï¶ó Àü»çü¿¡ ´ëÇÑ ´ë¿ë·® Á¤º¸ È®º¸ ¶ÇÇÑ ½Î°í ºü¸£°Ô ´Þ¼ºÇÒ ¼ö ÀÖ°Ô ÇØÁÖ°í ÀÖ´Ù. ±â¼úÀÇ ¹ß´ÞÀÌ µ¥ÀÌÅÍÀÇ È®º¸¸¦ ¿ëÀÌÇÏ°Ô ÇØ ÁÖ¾ú´Ù¸é, ¹®Á¦´Â ÀÌ·¯ÇÑ µ¥ÀÌÅ͸¦ ¾î¶»°Ô ºÐ¼®ÇÒ °ÍÀΰ¡ ÇÏ´Â ºÎºÐÀÌ´Ù. ¼ö½Ê ±â°¡¿¡ ´ÞÇÏ´Â ºÐ¼® Á¤º¸µéÀÌ ¼ö ½Ã°£ ¾È¿¡ ½ñ¾ÆÁ® ³ª¿ÀÁö¸¸, ÀÌ·¯ÇÑ µ¥ÀÌÅÍµé ¼Ó¿¡¼­ Á¦´ë·Î µÈ ºÐ¼® °á°ú¸¦ ¾ò±â¶õ ½¬¿î ÀÏÀÌ ¾Æ´Ï´Ù.
µ¥ÀÌÅÍ ºÐ¼®ÀÇ Ã¹ ¹ø° ´Ü°è´Â ¾î¶°ÇÑ µ¥ÀÌÅ͸¦ º¸°üÇÒ °ÍÀΰ¡ ÇÏ´Â °Í¿¡¼­ ½ÃÀ۵ȴÙ. ´Ü¼øÈ÷ ¿À¹Í½º Á¤º¸¸¦ ÃàÀûÇÑ´Ù°í Çؼ­ ±× µ¥ÀÌÅÍ°¡ Àǹ̸¦ °¡Áö´Â °ÍÀº ¾Æ´Ï´Ù. ¸ðµç ¿À¹Í½º µ¥ÀÌÅ͵鿡 À־ °¡Àå Áß¿äÇÑ Á¤º¸´Â ±× Àڽź¸´Ù´Â ±× ÀÚ½ÅÀÌ ¾ò¾îÁö°Ô µÈ ȯ°æÀû ¿äÀο¡ ´ëÇÑ ¸ÞŸ µ¥ÀÌÅÍ´Ù. ¾î¶°ÇÑ ±ÕÁÖ¿¡ ´ëÇÑ µ¥ÀÌÅÍÀÎÁö, ¾î¶°ÇÑ Á¶°Ç¿¡¼­ ÃßÃâÇÑ µ¥ÀÌÅÍÀÎÁö¸¦ Á¤È®ÇÏ°Ô ¾Ë°í ÀÖ¾î¾ß¸¸ À̵éÀ» ºñ±³ÇÑ °á°ú°¡ »ý¹°ÇÐÀû Àǹ̸¦ ºÎ¿©¹ÞÀ» ¼ö ÀÖ´Ù. µ¥ÀÌÅ͸¦ ¾òÀº »óȲ¿¡ ´ëÇÑ Á¤È®ÇÑ ¼³¸íÀÌ Á¸ÀçÇÏÁö ¾ÊÀ» °æ¿ì, À̸¦ ÀÌ¿ëÇÑ ºÐ¼®Àº À߸øµÈ °á°ú·Î ¿ÀµµµÉ ¼ö ÀÖ´Â ¿©Áö°¡ Á¸ÀçÇϱ⠶§¹®ÀÌ´Ù.
Minimum Information About a Microarray Experiment (MIAME) (Brazma, 2001), Minimum Information About a Proteomic Experiment (MIAPE) (Taylor, 2007, Martens, 2008) ±×¸®°í Minimum Information for Biological and Biomedical Investigation (MIBBI) project (Taylor, 2008) °°Àº Ç¥ÁصéÀº ¾î¶°ÇÑ ¸ÞŸ µ¥ÀÌÅ͵éÀÌ ¿À¹Í½º µ¥ÀÌÅÍÀÇ ºÐ¼®¿¡ ÀÖ¾î ÇʼöÀûÀÎ ¿ä¼ÒµéÀÎÁö¸¦ Á¦½ÃÇÏ°íÀÚ ÇÏ´Â ³ë·ÂÀÇ °á°ú¹°µéÀÌ´Ù. À̵éÀº °¢°¢ Àü»çü, ´Ü¹éÁúü, ±×¸®°í ±× ¿ÜÀÇ ´Ù¾çÇÑ »ý¹°ÇÐÀû ½ÇÇèµé¿¡ À־ ¾î¶°ÇÑ Á¤º¸°¡ »óÈ£°£ÀÇ ºñ±³¸¦ À§ÇØ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´ÂÁö¿¡ ´ëÇÑ °¡À̵å¶óÀÎÀ» Á¦½ÃÇÏ°í ÀÖ´Ù. ÀÌ·¯ÇÑ Ç¥ÁØÈ­µÈ ºñ±³ ±âÁØÀÌ ÀÖÀ» ¶§, ´Ù¾çÇÑ Ç÷§Æû°ú ´Ù¾çÇÑ Á¶°ÇÇÏ¿¡ ¾ò¾îÁø °¢Á¾ ¿À¹Í½º µ¥ÀÌÅ͵éÀÌ ¿À·ù ¾øÀÌ ºñ±³µÇ¾îÁú ¼ö ÀÖ´Ù (±×¸² 2).

 

±×¸² 2. MIBBI¿¡ Æ÷ÇÔµÈ ¸ÞŸµ¥ÀÌÅÍ Á¤º¸ ¿¹½Ã (Taylor, 2008)

 

3. ³×Æ®¿öÅ© À籸¼º ¼öÁØ º¥Ä¡¸¶Å· ¹æ¹ý Ç¥ÁØÈ­


´Ù¾çÇÑ ´ë¿ë·® ¿À¹Í½º µ¥ÀÌÅ͸¦ ¾òÀº ÀÌÈÄ À̸¦ ºÐ¼®ÇÒ ¶§ ´ÙÀ½À¸·Î ¹®Á¦°¡ µÇ´Â °ÍÀº, À̵éÀ» ÀÌ¿ëÇØ »ý¹°ÇÐÀû ³×Æ®¿öÅ©¸¦ À籸¼ºÇÏ°Ô µÉ °æ¿ì, °ú¿¬ ¾ó¸¶³ª Á¤È®ÇÏ°Ô À籸¼ºÀÌ µÇ¾ú´ÂÁö¸¦ ÆÇ´ÜÇϱ⠾î·Æ´Ù´Â ºÎºÐÀÌ´Ù. »ý¹°ÇÐÀû ³×Æ®¿öÅ©°¡ °¡Áö°í ÀÖ´Â º¹À⼺Àº ±× ¾È¿¡ Á¸ÀçÇÏ´Â ±¸¼º¿øµéÀÇ ¼öÀÇ Áõ°¡¿¡ µû¶ó ±âÇϱ޼öÀûÀ¸·Î Áõ°¡ÇÏ°Ô µÈ´Ù. ¶§¹®¿¡ ´Ü¼øÇÑ Å×½ºÆ®¸¸À¸·Î ÀÌµé ³×Æ®¿öÅ©°¡ ¾ó¸¶³ª Àß ±¸¼ºµÇ¾ú´ÂÁö¸¦ ÆÇ´ÜÇϱâ¶õ ºÒ°¡´ÉÇÏ´Ù. ±×·¸´Ù°í ¸ðµç °¡´É¼º¿¡ ´ëÇØ Å×½ºÆ®¸¦ ¼öÇàÇÏ´Â Àϵµ ºÒ°¡´É¿¡ °¡±õ´Ù.
´ëÁ¶±º ¼³°è´Â ¾ó¸¶³ª Àß ÀÌ·ç¾îÁ³´ÂÁö, »ùÇøµ ½ÃÁ¡Àº ¾î¶»°Ô Á¤ÇÏ¿´´ÂÁö, ¾ó¸¶³ª Á¤±³ÇÏ°Ô ¹Ýº¹ ½ÇÇèÀÌ µðÀÚÀεǾú´ÂÁö ÇÏ´Â ºÎºÐµéÀº ÃßÈÄ À籸¼ºµÇ´Â ³×Æ®¿öÅ©ÀÇ ½Å·Úµµ¸¦ Å©°Ô Á¿ìÇÏ°Ô µÈ´Ù. ¶ÇÇÑ, »ç¿ëµÈ Åë°èÇÐÀû ±â¹ý ³»Áö´Â ¼öÇÐÀû ¹æ¹ý·ÐµéÀº ¾î¶°ÇÑ °ÍÀÎÁö, ¾îµð±îÁö ¸ðµ¨ÀÌ ´Ü¼øÈ­µÇ¾î ÀÖ´ÂÁö, ¾î¶°ÇÑ °¡Á¤µéÀÌ »ç¿ëµÇ¾ú´ÂÁö¿¡ ´ëÇÑ ºÎºÐ ¿ª½Ã ³×Æ®¿öÅ© À籸¼º¿¡ ÀÖ¾î ±× Á¤È®µµ¿Í ½Å·Úµµ¿¡ Å« ¿µÇâÀ» ÁØ´Ù. Áö±Ý±îÁö ÀÌ·¯ÇÑ ºÎºÐ¿¡ À־ º¥Ä¡¸¶Å·À» À§ÇÑ ±âÁØÀÇ ºÎÀç°¡ ÇϳªÀÇ ¹®Á¦·Î ´ëµÎµÇ°í ÀÖ¾ú´Ù.
Dialogue for Reverse Engineering Assessments and Methods (DREAM) initiative (De Smet, 2010)´Â ÀÌ·¯ÇÑ ºÎºÐ¿¡ À־ ¼­·Î ´Ù¸¥ »ý¹°ÇÐÀû µ¥ÀÌÅÍ ¹× ³×Æ®¿öÅ© ºÐ¼® Á¤º¸µéÀ» ºñ±³ÇÒ ¼ö ÀÖ´Â ±âÁØÀ» Á¦½ÃÇÏ·Á´Â ½ÃµµÀÌ´Ù. DREAMÀ» ÅëÇØ ´Ù¾çÇÑ »ý¹°ÇÐÀû µ¥ÀÌÅ͵é°ú À̵éÀ» ºÐ¼®ÇÑ ´Ù¾çÇÑ Åë°èÇÐÀû ºÐ¼® ¹æ¹ý ³»Áö´Â ¼öÇÐÀû ¾Ë°í¸®ÁòµéÀÌ ºñ±³µÇ¾ú°í, ±× °á°ú ´Ù¾çÇÑ ¹æ¹ý·ÐµéÀÌ ÄÁÅؽºÆ®¿¡ ÀÇÁ¸ÀûÀ¸·Î ¼­·Î º¸¿ÏÀûÀÎ ±â´ÉÀ» ÇÒ ¼ö ÀÖÀ¸¸ç, À̸¦ ¹ÙÅÁÀ¸·Î ±×µé »çÀÌ¿¡¼­ °øÅëÀûÀ¸·Î ³ªÅ¸³ª´Â °á°ú¸¦ Á¾ÇÕÇØ ºÐ¼®ÇÔÀ¸·Î½á, ³ôÀº Ä÷¸®Æ¼ÀÇ ³×Æ®¿öÅ© À籸¼ºÀÌ °¡´ÉÇÏ´Ù´Â °ÍÀÌ È®ÀεǾú´Ù (±×¸² 3).


 

±×¸² 3. ¿À¹Í½ºµ¥ÀÌÅͷκÎÅÍ ³×Æ®¿öÅ©¸¦ À籸¼ºÇÏ°í º¥Ä¡¸¶Å·ÇÏ´Â °Í¿¡ ´ëÇÑ ¿¹½Ã (Schaffter, 2011)

 


4. »ý¹°ÇÐÀû ³×Æ®¿öÅ© Á¤º¸ ±â·Ï ¹æ¹ý Ç¥ÁØÈ­


³×Æ®¿öÅ©ÀÇ À籸¼ºÀÌ ¿øÈ°ÇÏ°Ô ÀÌ·ç¾îÁ³´Ù ÇÏ´õ¶óµµ, ÀÌ°ÍÀÌ È°¿ëÇϱ⠿ëÀÌÇÑ ¹æ½ÄÀ¸·Î µ¥ÀÌÅͺ£À̽ºÈ­µÇ¾îÀÖÁö ¾Ê´Ù¸é, À̸¦ È°¿ëÇϱâ¶õ ¿©°£ ¾î·Á¿î ÀÏÀÌ ¾Æ´Ï´Ù. ³×Æ®¿öÅ©ÀÇ ±¸¼º¿ä¼Ò ¹× ±× ¾È¿¡¼­ÀÇ »óÈ£ÀÛ¿ëÀ» »ç¶÷ÀÌ È¤Àº ÄÄÇ»ÅÍ°¡ Àб⠽±µµ·Ï ¸¸µé¾îÁÖÁö ¾Ê´Â´Ù¸é, ¸Å¹ø ÀÌ·¯ÇÑ Á¤º¸¸¦ ÄÄÇ»ÅÍ°¡ Àб⠽¬¿î ÇüÅ·ΠÀç°¡°øÇÏ´Â ÀÏÀÌ ÇÊ¿äÇÏ´Ù. ¿ªÀ¸·Î ÄÄÇ»Å͸¸ Àб⠽¬¿î ÇüÅ·ΠÁ¤º¸°¡ ÀúÀåµÇ¾î ÀÖÀ» °æ¿ì, À̸¦ »ç¶÷ÀÌ º¸°í È°¿ëÇϱⰡ ½±Áö ¾Ê´Ù.
µû¶ó¼­ ÀÌ·¯ÇÑ ³×Æ®¿öÅ©¿¡ ´ëÇÑ ´Ù¾çÇÑ Á¤º¸µéÀÌ ÄÄÇ»ÅÍ°¡ Àб⠽¬¿î ÇüÅ·Î, ȤÀº »ç¶÷ÀÌ Àб⠽¬¿î ÇüÅ·Π°¢°¢ ÀúÀåÇϱâ À§ÇÑ Ç¥ÁØÀÌ Á¸ÀçÇØ¾ß ÀÌ·¯ÇÑ Á¤º¸µéÀÌ ¼Õ½±°Ô È°¿ëµÉ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ÀÌµé »çÀÌÀÇ º¯È¯À» À§ÇÑ µµ±¸ÀÇ °³¹ßÀ» ÅëÇؼ­ »ç¶÷°ú ÄÄÇ»ÅÍ ¾çÂÊ ¸ðµÎ¿¡¼­ ÃÖ¼ÒÇÑÀÇ ³ë·ÂÀ» ÅëÇØ »ý¹°ÇÐÀû ³×Æ®¿öÅ©¿¡ ´ëÇÑ Á¤º¸¸¦ È°¿ëÇÒ ¼ö ÀÖ°Ô µÈ´Ù.
ÀÌ·¯ÇÑ Ç¥ÁØÈ­¿¡ ´ëÇÑ ³ë·ÂÀÇ °á°ú¹°·Î Systems Biology Markup Language (SBML) (Hucka, 2003)°ú Biological Pathways exchange (BioPAX) (Demir, 2010)ÀÇ °æ¿ì¿¡´Â ´Ù¾çÇÑ Bio-moleculeµé °£ÀÇ ³×Æ®¿öÅ©¸¦ ÄÄÇ»ÅÍ°¡ Àб⠽±°Ô Ç¥ÇöÇϱâ À§ÇÑ Ç¥ÁØÀ¸·Î °³¹ßµÇ¾î ³Î¸® »ç¿ëµÇ¾îÁö°í ÀÖ´Â ¹Ý¸é, Systems Biology Graphical Notation (SBGN) (Le Novere, 2009)ÀÇ °æ¿ì´Â »ç¶÷ÀÌ Àб⠴õ ÆíÇϵµ·Ï µµ½ÄÈ­ÇÏ¿© ±â·ÏÇϴ ǥÁØÀ¸·Î °³¹ßµÇ¾î »ç¿ëµÇ¾îÁö°í ÀÖ´Ù (±×¸² 4).

 

±×¸² 4.   SBGN diagram ¿¹½Ã (Le Novere, 2009)

 

5. ½Ã¹Ä·¹ÀÌ¼Ç ¸ÞŸµ¥ÀÌÅÍ ¹× °á°ú µ¥ÀÌÅÍ ±â·Ï ¹æ¹ý Ç¥ÁØÈ­


¿À¹Í½º µ¥ÀÌÅ͸¦ ¾ò¾î³»´Â µ¿¾ÈÀÇ º¯Àε鿡 ´ëÇÑ ¸ÞŸ µ¥ÀÌÅÍ, À̵éÀ» ÀÌ¿ëÇØ ³×Æ®¿öÅ©¸¦ À籸¼ºÇÏ´Â ¹æ½Ä¿¡ ´ëÇÑ ºñ±³, ³×Æ®¿öÅ©¸¦ ±â·ÏÇÏ°í ÀúÀåÇÏ´Â ¹æ½Äµé µî¿¡ ´ëÇÑ Ç¥ÁØÈ­µÈ ±âÁØµé ¿Ü¿¡ Ãß°¡ÀûÀ¸·Î ÇÊ¿äÇÑ °ÍÀÌ ÀÌ·¸°Ô À籸¼ºµÈ ³×Æ®¿öÅ©¸¦ ÀÌ¿ëÇØ ½Ã¹Ä·¹À̼ÇÀ» ¼öÇàÇßÀ» ¶§ ÀÌ¿¡ ´ëÇÑ Á¤º¸¸¦ ¾î¶»°Ô ÀúÀåÇÏ°í, ½Ã¹Ä·¹ÀÌ¼Ç °á°úÀÇ ºñ±³¿¡ È°¿ëÇÒ °ÍÀΰ¡¿¡ ´ëÇÑ Ç¥ÁØÈ­µÈ ±âÁØÀÌ´Ù.
Deterministic modelÀÎÁö stochastic modelÀÎÁö, dynamic modelÀÎÁö constraint-based modelÀÎÁö, partial differential equationÀ» »ç¿ëÇÏ´ÂÁö, ordinary differential equationÀ» »ç¿ëÇÏ´ÂÁö¿Í °°Àº ½Ã¹Ä·¹À̼ǿ¡ À־ÀÇ ¹æ¹ý·Ð¿¡ µû¶ó¼­ ½Ã¹Ä·¹ÀÌ¼Ç °á°ú°¡ ´Þ¶óÁú ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, µ¿ÀÏÇÑ ¹æ¹ý·ÐÀ» ÅëÇØ ³×Æ®¿öÅ©ÀÇ µ¿ÀÛÀ» ½Ã¹Ä·¹ÀÌ¼Ç ÇÏ´õ¶óµµ, ±× ¾È¿¡ Á¸ÀçÇÏ´Â ´Ù¾çÇÑ ÆĶó¹ÌÅ͵éÀÇ º¯È­¿¡ µû¶ó ½Ã¹Ä·¹ÀÌ¼Ç °á°ú°¡ Å©°Ô ´Þ¶óÁú ¼ö ÀÖ´Ù.
Áï, ÀÌ·¯ÇÑ ½Ã¹Ä·¹ÀÌ¼Ç ½ÇÇè¿¡ ´ëÇÑ »ç¿ëµÈ ÅøÀ̳ª ÆĶó¹ÌÅÍ¿¡ ´ëÇÑ ¸ÞŸ µ¥ÀÌÅ͵éÀ» ¾î¶»°Ô ±â·ÏÇÏ°í ÀúÀåÇÒ °ÍÀÎÁö¿¡ ´ëÇÑ Ç¥ÁØÈ­µÈ ±âÁØÀÌ Á¸ÀçÇؾß, ±× °á°úµéÀ» ¿À·ù ¾øÀÌ ºñ±³ÇÏ°í ºÐ¼®ÇÏ´Â °ÍÀÌ °¡´ÉÇØÁø´Ù.
Simulation Experiment Description Markup Language (SED-ML) (Waltemath, 2011)ÀÇ °æ¿ì¿¡´Â ½Ã¹Ä·¹À̼ǿ¡ »ç¿ëµÈ ¸ðµ¨ÀÇ Á¾·ù, °¢Á¾ ¼öÇÐÀû ÆĶó¹ÌÅ͵éÀÇ ¼öÄ¡µé ¹× ¾Æ¿ôDzÀÇ Çü½Ä¿¡ ´ëÇÑ Á¤º¸¸¦ XML Çü½ÄÀ¸·Î ´ãµµ·Ï Çϴ ǥÁØÀ¸·Î °³¹ßµÇ¾ú´Ù (±×¸² 5). Systems Biology Results Markup Language (SBRML) (Dada, 2010)Àº SBMLÀ» º¸¿ÏÇϱâ À§ÇØ °³¹ßµÈ Ç¥ÁØÀ¸·Î, SBML ¸ðµ¨À» ÀÌ¿ëÇØ ½Ã¹Ä·¹À̼ÇÀ» ¼öÇàÇÑ °á°úµéÀ» ¾î¶»°Ô ÀúÀåÇÒ °ÍÀÎÁö¸¦ ÁöÁ¤ÇÏ°í ÀÖ´Ù.


 

±×¸² 5.  SED-MLÀ» ÅëÇØ ±â·ÏµÇ´Â ½Ã¹Ä·¹ÀÌ¼Ç Á¤º¸ (Waltemath, 2011)

 

6. °íÂû


´Ù¾çÇÑ ¿À¹Í½º µ¥ÀÌÅÍÀÇ ½Ã½ºÅÛ ¼öÁØ¿¡¼­ÀÇ ºÐ¼® ¹× ½Ã¹Ä·¹À̼ÇÀ» À§ÇÑ ±â¼úµéÀÇ ±Þ°ÝÇÑ ¹ßÀüÀº, °ü·Ã ³í¹®µé°ú µ¥ÀÌÅ͵éÀÇ ±âÇϱ޼öÀûÀÎ Áõ°¡¶ó´Â °á°ú·Î ³ªÅ¸³ª°í ÀÖ´Ù. ±×·¯³ª À̵鿡 ´ëÇÑ Á¦´ë·Î µÈ Ç¥ÁØÈ­°¡ ÀÌ·ç¾îÁöÁö ¾ÊÀ» °æ¿ì, ±¤´ëÇÑ µ¥ÀÌÅ͵éÀÌ ¼­·Î ¿¬°èµÇ¾î ºÐ¼®µÇÁö ¸øÇÏ°í »çÀåµÇ±â ½Ê»óÀÌ´Ù. µû¶ó¼­ ¿À¹Í½º µ¥ÀÌÅ͵éÀº ½Àµæ¿¡¼­ºÎÅÍ ÀúÀå, ºÐ¼® ¹× ½Ã¹Ä·¹À̼ǿ¡ À̸£±â±îÁöÀÇ ¸ðµç °úÁ¤µéÀÌ Ç¥ÁØÈ­µÈ ±âÁØ¿¡ µû¶ó ±× ¼³Á¤°ú °á°ú µ¥ÀÌÅ͵éÀÌ ÇÔ²² ÀúÀåµÇ°í ºÐ¼®µÇ¾î¾ß Çϸç, ÀÌ°ÍÀÌ ÀÌ·ç¾îÁ³À» ¶§ À̵éÀ» ¹ÙÅÁÀ¸·Î ÇÑ ½Ã½ºÅÛÀÇ ¼³°è ¹× ÇÕ¼ºÀÌ ¼º°øÀûÀ¸·Î ¼öÇàµÉ ¼ö ÀÖÀ» °ÍÀÌ´Ù.

 

Âü°í¹®Çå

 

1. Tyson, J. J., Chen, K. & Novak, B., Network dynamics and cell physiology, 2001, Nature Rev. Mol. Cell Biol., 2, 908-16.
2. Novak, B. & Tyson, J. J., Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos, 1993, J. Cell Sci., 106, 1153–68.
3. Chen, K. C. et al., Integrative analysis of cell cycle control in budding yeast, 2004, Mol. Biol. Cell, 15, 3841–62.
4. Kitano, H., Systems biology: a brief overview, 2002, Science, 295, 1662–4.
5. Kitano, H., Computational systems biology, 2002, Nature, 420, 206–10.
6. Kitano, H., Perspectives on systems biology, 2000, New Generation Computing, 18, 199–216.
7. Ideker, T., Galitski, T. & Hood, L., A new approach to decoding life: systems biology, 2001, Annu. Rev. Genomics Hum. Genet., 2, 343–72.
8. Schoeberl, B. et al., An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation, 2010, Cancer Res., 70, 2485–94.
9. Lanza, A. M., Crook, N. C. & Alper, H. S., Innovation at the intersection of synthetic and systems bioloogy, 2012, Curr. Opin. Biotech., 23, 712-7.
10. Brazma, A. et al., M., Minimum information about a microarray experiment (MIAME) — toward standards for microarray data, 2001, Nature Genet., 29, 365–71.
11. Taylor, C. F. et al., The minimum information about a proteomics experiment (MIAPE), 2007, Nature Biotech., 25, 887–93.
12. Martens, L., Palazzi, L. M. & Hermjakob, H., Data standards and controlled vocabularies for proteomics, 2008, Methods Mol. Biol., 484, 279–86.
13. Taylor, C. F. et al., Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project, 2008, Nature Biotech., 26, 889–96.
14. De Smet, R. & Marchal, K., Advantages and limitations of current network inference methods, 2010, Nature Rev. Microbiol., 8, 717–729.
15. Schaffter, T., Marbach, D. & Floreano, D., GeneNetWeaver: in silico benchmark generation and performance profiling of network inference methods, 2011, Bioinformatics, 27, 2263-70.
16. Hucka, M. et al., The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models, 2003, Bioinformatics, 19, 524–31.
17. Demir, E. et al., The BioPAX community standard for pathway data sharing, 2010, Nature Biotech., 28, 935–42.
18. Le Novere, N. et al., The Systems Biology Graphical Notation, 2009, Nature Biotech., 27, 735–41.
19. Waltemath, E. et al., Reproducible computational biology experiments with SED-ML – the Simulation Experiment Description Markup Language, 2011, BMC Syst. Biol., 5:198.
20. Dada, J. O. et al., SBRML: a markup language for associating systems biology data with models, 2010, Bioinformatics, 26:932-8.




Total:118 page:(8/7)
22 Á¤º¸ ÀÌÁ¤°É ÇÕ¼º»ý¹°ÇÐ ºÎÇ° °³·®À» À§ÇÑ ´Ü¹éÁú°øÇÐÀÇ ¿¬±¸.. 14.03.04 21952
21 Á¤º¸ ÀÌÁö¿¬ Light signaling proteinÀÇ ±â´É ¹× ¹ÙÀÌ¿À ºÎÇ°.. 14.03.04 10841
20 Á¤º¸ ÀÌ¿µÈÆ ´ëÀå±Õ ncRNAÀÇ ÇÕ¼º »ý¹°ÇÐ ¹× ÀÌÀÇ ÀÀ¿ë 13.11.06 14287
19 Á¤º¸ À̼º±¹ Genome engineeringÀ» ÅëÇÑ Áö´ÉÇü Àΰø¹Ì»ý¹° °³.. 13.11.05 19577
18 Á¤º¸ ÀÌ»ó¿± ¹Ì»ý¹°¿¡¼­ÀÇ ÇÕ¼º»ý¹°ÇÐÀû ±â¹ýÀ» ÀÌ¿ëÇÑ À¯ÀüÀÚ.. 13.10.24 15856
17 Á¤º¸ À̱չΠCHO ¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ½Ã½ºÅÛ »ý¹°ÇÐ ¹× ÇÕ¼º »ý¹°ÇÐ.. 13.09.24 10569
16 Á¤º¸ ³ëÁ¤Çý ÇÕ¼ºÀ¯ÀüÀÚÀÇ ¹ßÇöÀ» À§ÇÑ ÀÌÁ¾¼÷ÁÖÀÇ genome eng.. 13.09.24 16172
15 Á¤º¸ ISBC [Nature Biotechnology_News] Synthetic biology .. 13.09.11 7560
14 Á¤º¸ À±¿©ÁØ ¹æ¼±±Õ ÀÌÁ¾¼÷ÁÖ »ý»ê½Ã½ºÅÛÀÇ ¿¬±¸ µ¿Çâ 13.09.02 15149
13 Á¤º¸ ±è ÇÊ ¼¼Æ÷¿¡³ÊÁö Á¦¾î ¹ÙÀÌ¿À½Ã½ºÅÛÀÇ °³¹ß ¹× ¿ë¿ë(°¡.. 13.07.01 11484
12 Á¤º¸ ±èÁöÇö ½Ã½ºÅÛ»ý¹°ÇÐÀÇ ÇÕ¼º»ý¹°ÇÐ Àû¿ëÀ» À§ÇÑ Ç¥ÁØÈ­(.. 13.07.01 14297
11 Á¤º¸ ±è¼±¿ø Áö´ÉÇü ¼¼Æ÷´ë»çÁ¶Àý ½Ã½ºÅÛÀÇ ÃÖ±Ùµ¿Çâ(°æ»ó´ë .. 13.07.01 13295
10 Á¤º¸ ±èµ¿ÈÆ ¼¼Æ÷¸· Á¦¾î ±â¼úÀÇ Àû¿ëÀ» ÅëÇÑ Áö¹æ»ê »ý»ê(ÇÑ.. 13.05.20 18979
9 Á¤º¸ ±èµ¿¸í ÇÕ¼º »ý¹°Çп¡¼­ÀÇ ¹«¼¼Æ÷ ´Ü¹éÁú ÇÕ¼º ½Ã½ºÅÛÀÇ .. 13.05.06 20251
8 Á¤º¸ ±è±ÙÁß ¼¼Æ÷Á¦¾î Àΰø À¯Àüȸ·Î ¿¬±¸µ¿Çâ(Àü³²´ë ±è±ÙÁß .. 13.04.04 18523
7 Á¤º¸ ±Ç¿À¼® 2°³-ÀÎÀÚ ½ÅÈ£Àü´Þ°è¸¦ ÀÌ¿ëÇÑ Àΰø½ÅÈ£Àü´Þ°è °³.. 13.03.18 14387
[1] [2] [3] [4] [5] [6] [7] [8]